Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ4114124,04
KB486487,63,31
PKN53,6253,642,21
Msft7,03
Nokia2,84952,85453,33
IBM4,54
Daimler AG28,64528,685,40
PFE5,73
31.03.2020 10:03:00
Indexy online
AD Index online
select
AD Index online
 

  • 30.03.2020
Zimmer Hldgs (ZMH, NY Consolidated)
Závěr k 30.3.2020 Změna (%) Změna (USD) Objem obchodů (ks)
98,28 3,52 3,34 2 024 774
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 31.03.2020
Popis společnosti
Obecné informace
Název společnostiZimmer Biomet Holdings Inc
TickerZBH
Kmenové akcie:Ordinary Shares
RICZBH
ISINUS98956P1021
Poslední známé roční výsledky31.12.2019
Poslední známé čtvrtletní výsledky31.12.2019
Počet zaměstnanců k 31.12.2019 19 900
Akcie v oběhu k 09.03.2020 206 681 600
Počet akcionářů k 31.12.2019 17 900
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice345 E Main St
MěstoWARSAW
PSČ46580-2746
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon15 742 676 131
Fax13026365454

Business Summary: Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2019, Zimmer Biomet Holdings Inc revenues increased 1% to $7.98B. Net income before extraordinary items totaled $1.13B vs. loss of $370.9M. Revenues reflect Asia Pacific segment increase of 5% to $1.3B, Americas segment increase of 1% to $3.98B. Net Income reflects Americas segment income increase of 5% to $2.16B, Asia Pacific segment income increase of 7% to $458.9M. Dividend per share remained flat at $0.96.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution - NEC
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSMedical, Dental and Hospital Equipment and Supplies Wholesalers
SICSurgical Appliances And Supplies
SICSurgical And Medical Instruments
SICMedical And Hospital Equipment



  • Poslední aktualizace: 31.03.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorBryan Hanson5219.12.201719.12.2017
Chief Financial Officer, Executive Vice PresidentSuketu Upadhyay5001.07.201901.07.2019
Group President, Spine, CMF, Thoracic and Surgery Assisting TechnologyAure Bruneau44
Group President, OrthopedicsIvan Tornos4301.11.201801.11.2018
President, Asia PacificSang Yi56
Senior Vice President, General Counsel, SecretaryChad Phipps47
Senior Vice President - Investor Relations, Chief Communications OfficerKeri Mattox-08.01.202008.01.2020
Chief Accounting Officer, Vice President, ControllerCarrie Nichol4001.10.201901.10.2019